Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marieta M Ruseva

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2013
Purification and characterization of human and mouse complement C3Marieta M Ruseva, Meike Heurich
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2014
Update on C3 glomerulopathyThomas D Barbour, Marieta M Ruseva, Matthew C Pickering
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in miceMarieta M Ruseva, Valeria Ramaglia, B Paul Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 28, 2010
Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanismsMartin V Kolev, Marieta M Ruseva, B Paul Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2011
Retraction. Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanismsMartin V Kolev, B Paul Morgan, Marieta M Ruseva, et al.
Current Neuropharmacology|September 2, 2009
Implication of complement system and its regulators in Alzheimer's diseaseMartin V Kolev, Marieta M Ruseva, Claire L Harris, et al.
Journal of the American Society of Nephrology : JASN|September 17, 2015
Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic MicroangiopathyKatherine A Vernon, Marieta M Ruseva, H Terence Cook, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2014
C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigensLucie Baudino, Alessandro Sardini, Marieta M Ruseva, et al.
Kidney International|March 1, 2016
Complement receptor 3 mediates renal protection in experimental C3 glomerulopathyThomas D Barbour, Guang Sheng Ling, Marieta M Ruseva, et al.
Molecular Immunology|October 25, 2008
Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injuryMarieta M Ruseva, Timothy R Hughes, Rossen M Donev, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2013
Purification and characterization of human and mouse complement C3Marieta M Ruseva, Meike Heurich
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2014
Update on C3 glomerulopathyThomas D Barbour, Marieta M Ruseva, Matthew C Pickering
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in miceMarieta M Ruseva, Valeria Ramaglia, B Paul Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 28, 2010
Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanismsMartin V Kolev, Marieta M Ruseva, B Paul Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2011
Retraction. Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanismsMartin V Kolev, B Paul Morgan, Marieta M Ruseva, et al.
Current Neuropharmacology|September 2, 2009
Implication of complement system and its regulators in Alzheimer's diseaseMartin V Kolev, Marieta M Ruseva, Claire L Harris, et al.
Journal of the American Society of Nephrology : JASN|September 17, 2015
Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic MicroangiopathyKatherine A Vernon, Marieta M Ruseva, H Terence Cook, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2014
C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigensLucie Baudino, Alessandro Sardini, Marieta M Ruseva, et al.
Kidney International|March 1, 2016
Complement receptor 3 mediates renal protection in experimental C3 glomerulopathyThomas D Barbour, Guang Sheng Ling, Marieta M Ruseva, et al.
Molecular Immunology|October 25, 2008
Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injuryMarieta M Ruseva, Timothy R Hughes, Rossen M Donev, et al.
Pageof 2